DMRTC1B
gene geneOn this page
Summary
DMRTC1B (DMRT like family C1B, HGNC:31686) is a protein-coding gene on chromosome Xq13.1, encoding Doublesex- and mab-3-related transcription factor C1 (Q5HYR2).
Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 728656 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001386972
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31686 |
| Approved symbol | DMRTC1B |
| Name | DMRT like family C1B |
| Location | Xq13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000184911 |
| Ensembl biotype | protein_coding |
| Entrez | 728656 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 nonsense_mediated_decay
ENST00000334036, ENST00000373532, ENST00000373533, ENST00000438696, ENST00000440247, ENST00000472595, ENST00000481112
RefSeq mRNA: 3 — MANE Select: NM_001386972
NM_001080851, NM_001370147, NM_001386972
CCDS: CCDS43971, CCDS94635
Canonical transcript exons
ENST00000334036 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001361867 | 72776890 | 72777248 |
| ENSE00001683107 | 72845499 | 72845557 |
| ENSE00001686349 | 72845872 | 72846005 |
| ENSE00001689658 | 72846885 | 72846945 |
| ENSE00002179619 | 72845042 | 72845199 |
| ENSE00003621433 | 72847130 | 72847277 |
| ENSE00003919825 | 72848263 | 72848803 |
Expression profiles
Bgee: expression breadth ubiquitous, 122 present calls, max score 95.79.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1204 / max 9.1062, expressed in 61 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 209734 | 0.1204 | 61 |
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.79 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.41 | gold quality |
| pituitary gland | UBERON:0000007 | 89.72 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.21 | gold quality |
| hypothalamus | UBERON:0001898 | 89.08 | gold quality |
| prefrontal cortex | UBERON:0000451 | 88.56 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.15 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 88.09 | gold quality |
| frontal cortex | UBERON:0001870 | 87.85 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.82 | gold quality |
| caudate nucleus | UBERON:0001873 | 87.53 | gold quality |
| putamen | UBERON:0001874 | 87.43 | gold quality |
| cerebral cortex | UBERON:0000956 | 87.29 | gold quality |
| amygdala | UBERON:0001876 | 87.27 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.23 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 87.16 | gold quality |
| temporal lobe | UBERON:0001871 | 87.01 | gold quality |
| brain | UBERON:0000955 | 86.08 | gold quality |
| Ammon’s horn | UBERON:0001954 | 85.38 | gold quality |
| primary visual cortex | UBERON:0002436 | 85.22 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.55 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.48 | gold quality |
| cerebellum | UBERON:0002037 | 80.45 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.27 | gold quality |
| substantia nigra | UBERON:0002038 | 79.56 | gold quality |
| right testis | UBERON:0004534 | 76.81 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.96 | gold quality |
| ventricular zone | UBERON:0003053 | 75.57 | gold quality |
| cortical plate | UBERON:0005343 | 75.08 | gold quality |
| left testis | UBERON:0004533 | 75.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
29 targeting DMRTC1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4643 | 99.49 | 67.63 | 1791 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-6761-5P | 98.71 | 68.03 | 1504 |
| HSA-MIR-7850-5P | 98.12 | 67.28 | 1111 |
| HSA-MIR-4421 | 97.99 | 64.89 | 701 |
| HSA-MIR-4257 | 97.86 | 68.05 | 1190 |
| HSA-MIR-5699-3P | 97.81 | 65.00 | 861 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-3189-5P | 97.55 | 66.71 | 655 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
| HSA-MIR-4475 | 97.36 | 66.95 | 761 |
| HSA-MIR-1243 | 97.07 | 65.44 | 719 |
| HSA-MIR-3622A-3P | 97.06 | 66.43 | 1000 |
| HSA-MIR-3622B-3P | 96.82 | 66.36 | 988 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | dmrt99B | FBGN0039683 |
| caenorhabditis_elegans | WBGENE00007776 | |
| caenorhabditis_elegans | WBGENE00017326 | |
| caenorhabditis_elegans | WBGENE00019521 | |
| caenorhabditis_elegans | WBGENE00022060 |
Paralogs (8): DMRT3 (ENSG00000064218), DMRT1 (ENSG00000137090), DMRTC2 (ENSG00000142025), DMRTA2 (ENSG00000142700), DMRTB1 (ENSG00000143006), DMRT2 (ENSG00000173253), DMRTA1 (ENSG00000176399), DMRTC1 (ENSG00000269502)
Protein
Protein identifiers
Doublesex- and mab-3-related transcription factor C1 — Q5HYR2 (reviewed: Q5HYR2)
All UniProt accessions (5): Q5HYR2, A0A0C4DG55, A0A1B0GX16, G3V190, H0YDN8
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Predominantly expressed in kidney, pancreas, ovary and testis. Detected in brain and in many other tissues.
Similarity. Belongs to the DMRT family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5HYR2-1 | 1 | yes |
| Q5HYR2-2 | 2 |
RefSeq proteins (3): NP_001074320, NP_001357076, NP_001373901* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026607 | DMRT | Family |
| IPR031577 | DMRT-C1/C2_C | Domain |
Pfam: PF15791
UniProt features (3 total): chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5HYR2-F1 | 63.45 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrXq13, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR196A_1_3P, MIR507, MIR4524A_3P, MIR557, MIR5699_3P, MIR4475, MIR3189_5P, MIR4421, GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP, GSE20366_TREG_VS_TCONV_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (0):
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
250 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DMRTC1B | UBN2 | Q6ZU65 | 427 |
| DMRTC1B | CHIC1 | Q5VXU3 | 396 |
| DMRTC1B | TTLL4 | Q14679 | 389 |
| DMRTC1B | CTPS2 | Q9NRF8 | 336 |
| DMRTC1B | RLIM | Q9NVW2 | 325 |
| DMRTC1B | RFX2 | P48378 | 321 |
| DMRTC1B | SEL1L2 | Q5TEA6 | 308 |
| DMRTC1B | HS6ST2 | Q96MM7 | 300 |
| DMRTC1B | CDX4 | O14627 | 296 |
| DMRTC1B | DMRT1 | Q9Y5R6 | 279 |
| DMRTC1B | IL1RAPL1 | Q9NZN1 | 270 |
| DMRTC1B | SLC7A2 | P52569 | 262 |
| DMRTC1B | EFCAB5 | A4FU69 | 245 |
| DMRTC1B | TMEM125 | Q96AQ2 | 245 |
| DMRTC1B | WSCD1 | Q658N2 | 244 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DMRTC1 | SIN3A | psi-mi:“MI:0915”(physical association) | 0.370 |
| DMRTC1 | PTPN11 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (3): DMRTC1 (Two-hybrid), DMRTC1B (Two-hybrid), DMRTC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP49, A0A1B0GVZ6, A0A1W2PR82, A5PL33, A6NDZ8, A6NE82, A6NJB7, A6QP24, A8MYA2, A8MZG2, B2RW88, D4AAA5, H7C350, O43593, O60393, O75593, O88621, P0C1T1, P59942, Q0P5M0, Q2KIS6, Q32LE6, Q3UN58, Q3ZCQ2, Q5BMD4, Q5HYR2, Q5JPB2, Q5M844, Q5SZB4, Q5VZ46, Q6GQX2, Q6NS69, Q6PAC4, Q80TS7, Q8BT88, Q8CGW9, Q8IWN7, Q8IXT2, Q8IYS4, Q8N1L9
Diamond homologs: A2A9A2, A2A9I7, A4QNP7, A6QQ94, A8TSS9, B0I1G7, B7ZS42, C0LZJ1, D4A218, F6W2R2, G5EEJ1, J7FCF0, O18214, P23023, P57690, P83758, P85119, Q18248, Q19291, Q2I327, Q2MJB4, Q32LE6, Q3LH63, Q4AE28, Q4QR87, Q5HYR2, Q5UU75, Q5VZB9, Q6YHU8, Q71MM5, Q76L87, Q801F8, Q80WT2, Q8BG36, Q8CFG4, Q8CGW9, Q8IXT2, Q8JIR6, Q90WM5, Q96MA1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1474 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:72845200:G:GG | donor_gain | 1.0000 |
| X:72845496:C:G | acceptor_gain | 1.0000 |
| X:72845497:A:AG | acceptor_gain | 1.0000 |
| X:72845497:AGCT:A | acceptor_gain | 1.0000 |
| X:72845497:AGCTG:A | acceptor_gain | 1.0000 |
| X:72845498:G:GA | acceptor_gain | 1.0000 |
| X:72845498:GCT:G | acceptor_gain | 1.0000 |
| X:72845498:GCTG:G | acceptor_gain | 1.0000 |
| X:72845498:GCTGG:G | acceptor_gain | 1.0000 |
| X:72846954:A:T | donor_gain | 1.0000 |
| X:72845131:G:GT | donor_gain | 0.9900 |
| X:72845131:GGA:G | donor_gain | 0.9900 |
| X:72845132:GAG:G | donor_gain | 0.9900 |
| X:72845197:TCAG:T | donor_loss | 0.9900 |
| X:72845198:CA:C | donor_gain | 0.9900 |
| X:72845198:CAGTG:C | donor_loss | 0.9900 |
| X:72845199:AGTG:A | donor_loss | 0.9900 |
| X:72845200:G:A | donor_loss | 0.9900 |
| X:72845201:TGAG:T | donor_loss | 0.9900 |
| X:72845202:GAGTG:G | donor_loss | 0.9900 |
| X:72845486:T:TA | acceptor_gain | 0.9900 |
| X:72845495:A:AG | acceptor_gain | 0.9900 |
| X:72845496:CA:C | acceptor_loss | 0.9900 |
| X:72845497:A:T | acceptor_loss | 0.9900 |
| X:72845498:GC:G | acceptor_gain | 0.9900 |
| X:72845554:GGAG:G | donor_gain | 0.9900 |
| X:72845555:G:GT | donor_gain | 0.9900 |
| X:72845557:GGT:G | donor_loss | 0.9900 |
| X:72845558:G:GA | donor_loss | 0.9900 |
| X:72845559:T:A | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1009696 (X:72793108 T>G), RS1011191 (X:72804534 C>G,T), RS1011192 (X:72804543 A>T), RS10556407 (X:72807289 CGAG>C), RS111254771 (X:72840625 A>G), RS111269034 (X:72801935 A>C), RS111437717 (X:72817897 T>A), RS111521282 (X:72841088 A>G), RS111547771 (X:72809082 A>G), RS111813604 (X:72813592 A>G), RS112116526 (X:72821105 T>A), RS112142053 (X:72830665 G>A), RS112142708 (X:72801934 C>A), RS112183524 (X:72802651 A>C), RS112186105 (X:72848201 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.